Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2010
08/26/2010WO2010094944A1 Retention of a stem cell phenotype
08/26/2010WO2010094773A2 A brewing method
08/26/2010WO2010094757A1 Use of primary human cardiomyocytes
08/26/2010WO2010094747A1 Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies
08/26/2010WO2010094698A2 Switchable affinity binders
08/26/2010WO2010094280A1 Novel permanent human cell line
08/26/2010WO2010094128A1 Tissue-engineered cartilage from continuous flow culture
08/26/2010WO2010071692A3 Methods for propagation of renal precursor cells
08/26/2010WO2010068897A3 Stem cell enhanced protein products and uses thereof
08/26/2010WO2010053987A3 Monoclonal antibody production in b cells and uses therof
08/26/2010WO2010045002A3 Gene therapy vectors and cytosine deaminases
08/26/2010WO2010033920A3 Compositions and methods for enhancing cell reprogramming
08/26/2010WO2009090190A9 Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene
08/26/2010US20100218283 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof
08/26/2010US20100218282 Nucleic acid molecules from rice controlling abiotic stress tolerance
08/26/2010US20100218281 Insect resistant cotton plants and methods for identifying same
08/26/2010US20100218280 Defensin-Encoding Nucleic Acid Molecules Derived From Nicotiana Alata, Uses Therefor and Transgenic Plants Comprising Same
08/26/2010US20100218279 Plant resistance to banana bunchy top virus
08/26/2010US20100218277 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained
08/26/2010US20100218274 Constitutive promoter from oil palm
08/26/2010US20100218269 obtaining soybean plants that produce seed with low linolenic acid and moderately increased oleic levels; combination of transgenes that provide both moderate oleic acid and low saturated fat levels with soybean germplasm that contains mutations in soybean genes that confer low linolenic acid phenotypes
08/26/2010US20100218263 Transgenic mollusk and method for producing the same
08/26/2010US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene
08/26/2010US20100216883 Method of using abscisic acid to treat and prevent diseases and disorders
08/26/2010US20100216870 Novel Genes Encoding a Nystatin Polyketide Synthase and Their Manipulation and Utility
08/26/2010US20100216868 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
08/26/2010US20100216864 RNA Antagonist Compounds for the Modulation of PCSK9
08/26/2010US20100216862 Pyrrole Derivatives As Therapeutic Compounds
08/26/2010US20100216851 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
08/26/2010US20100216811 Furo[3. 2-b] pyrrol derivatives
08/26/2010US20100216805 Modulation of neurogenesis using d-cycloserine combinations
08/26/2010US20100216720 Antibodies to troponin i and methods of use thereof
08/26/2010US20100216717 Hypoallergenic Mutant Polypeptides Based on Fish Parvalbumin
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
08/26/2010US20100216713 Novel compositions and methods in cancer associated with altered expression of prlr
08/26/2010US20100216712 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
08/26/2010US20100216710 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
08/26/2010US20100216708 Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses
08/26/2010US20100216706 Ghrelin Protects Substantia Nigra Dopamine Neurons
08/26/2010US20100216651 Viral polyhedra complexes and methods of use
08/26/2010US20100216643 Control of plant stress tolerance, water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists
08/26/2010US20100216245 Frozen cell immobilized product, primary hepatocyte culture tool, and method for producing primary hepatocyte culture tool
08/26/2010US20100216244 Microfluidic Chip and Method Using the Same
08/26/2010US20100216243 Metal alginate hydrogel and articles thereof
08/26/2010US20100216242 Cell culture support and production method and uses thereof
08/26/2010US20100216241 Forming cell structure with transient linker in cage
08/26/2010US20100216240 Non-invasive automated cell proliferation apparatus
08/26/2010US20100216239 Isolated nature-identical collagen
08/26/2010US20100216238 Compositions and methods for modulation of smn2 splicing
08/26/2010US20100216237 Optimized and defined method for isolation and preservation of precursor cells from human umbilical cord
08/26/2010US20100216236 Nuclear reprogramming factor and induced pluripotent stem cells
08/26/2010US20100216235 Dipeptidyl peptidases
08/26/2010US20100216234 Anti-IL-12 Antibody Based Vectors, Host Cells, and Methods of Production and Uses
08/26/2010US20100216233 Attenuated invasive e.coli strains and applications thereof as intracellular vector for therapeutic molecule
08/26/2010US20100216232 Mammal dedicated cell line
08/26/2010US20100216210 Methods and compositions for repair of cartilage using an in vivo bioreactor
08/26/2010US20100216206 Method for Preparing an Acellular Organic Tissue for Revitalisation and Device for Implementing Said Method
08/26/2010US20100216189 Synthetic repetitive proteins, the production and use thereof
08/26/2010US20100216187 Amino acid sequences that bind to a desired molecule in a conditional manner
08/26/2010US20100216181 Methods and compositions for the differentiation of stem cells
08/26/2010US20100216140 Novel Human Dickkopf-Related Protein and Nucleic Acid Molecules and uses Therefor
08/26/2010US20100216116 Viral latency model
08/26/2010US20100215760 Intrinscially fluorescent carbon nanospheres and a process thereof
08/26/2010US20100215729 Oligonucleotide analogues incorporating 5-aza-cytosine therein
08/26/2010US20100215714 Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells
08/26/2010US20100215696 Efficiently replicable heptitis c virus mutant, a heptitis c virus mutant comprising reporter gene, a method of preparing of hcv vaccine using the same and a method of screening anti hcv composition using the same
08/26/2010US20100215693 Immunological herpes simplex virus antigens and methods for use thereof
08/26/2010US20100215690 Circovirus sequences associated with piglet weight loss disease (pwd)
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215682 Deletion of the beta 20-21 loop in hiv gp120 exposes the cd4 binding site for improved antibody binding and antibody induction
08/26/2010US20100215677 Pdz domain interactions and lipid rafts
08/26/2010US20100215676 Kdr peptides and vaccines comprising the same
08/26/2010US20100215674 Enhancing the t-cells stimulatory capacity of human antigen presenting cells and their use in vaccination
08/26/2010US20100215669 Anti-cd79b antibodies and immunoconjugates and methods of use
08/26/2010US20100215666 Il-17 antagonistic antibodies
08/26/2010US20100215660 Kruppel-like factors and fat regulation
08/26/2010US20100215658 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215655 Angiogenesis-inhibiting chimeric proteins and the use
08/26/2010US20100215651 Humanized antibodies that bind to CD19 and their uses
08/26/2010US20100215629 Treatment of tumors using t lymphocyte preparations
08/26/2010US20100215628 Method for preparing cell populations with anti-tumor immune response activity
08/26/2010US20100215625 Efficient preparation of naphthoquinone anticancer active ingredients
08/26/2010US20100215624 Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell
08/26/2010US20100215619 Hla peptide therapy
08/26/2010US20100215573 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
08/26/2010DE102009003439A1 Neue permanente humane Zelllinie New permanent human cell line
08/26/2010DE102008064667A1 Verfahren zur Herstellung eines Detektionskonjugats A method for producing a Detektionskonjugats
08/26/2010CA2790214A1 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
08/26/2010CA2753303A1 Culture medium and method for inducing differentiation into bone cells
08/26/2010CA2753299A1 Culture medium and method for inducing differentiation into adipocytes
08/26/2010CA2753208A1 Methods and compositions for the differentiation of stem cells
08/26/2010CA2752869A1 Compositions for treating an allergic or asthmatic condition
08/26/2010CA2752729A1 Cell culture media containing combinations of proteins
08/26/2010CA2752679A1 Isolated monocyte populations and related therapeutic applications
08/26/2010CA2752560A1 Foxm1 peptides and vaccines containing the same
08/26/2010CA2751985A1 Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies
08/26/2010CA2751497A1 Novel permanent human cell line
08/25/2010EP2221381A2 Promoters for regulation of plant expression
08/25/2010EP2221374A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor